Sector Chart Evolent Health, Inc.

Equities

Market Closed - Nyse Other stock markets 16:00:01 2024-05-15 EDT			5-day change	1st Jan Change
23.55 ^USD	-1.26%		-13.64%	-28.70%

05-14	Truist Adjusts Evolent Health's Price Target to $28 From $34, Notes Near-Term Lack of Claims Visibility; Keeps Hold Rating	MT
05-10	UBS Trims Price Target on Evolent Health to $44 From $46, Keeps Buy Rating	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes